Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
Aperiam Bio has raised $9.0M in total funding. The most recent round was Seed. The last funding was announced in November 2023.
Aperiam Bio's investors include Civilization Ventures, OMX Ventures, KdT Ventures, Axial VC, Saya Bio.
Aperiam Bio is headquartered in Austin, United States.
Aperiam Bio partners with enzyme engineers to create and share stabilized, solubilized, and catalytically optimized proteins.
Aperiam Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Aperiam Bio — Funding & Investors." VCBacked, November 29, 2023, https://www.vcbacked.co/company/aperiam-bio. Accessed October 30, 2026.
VCBacked. (2023). Aperiam Bio — Funding & Investors. Retrieved October 30, 2026, from https://www.vcbacked.co/company/aperiam-bio
{{cite web |title=Aperiam Bio — Funding & Investors |url=https://www.vcbacked.co/company/aperiam-bio |website=VCBacked |access-date=October 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated